Feeds:
Posts
Comments

Posts Tagged ‘Obama’

Bloomberg News (3/5, Randall) reports, “Americans may soon be able to buy cheap drugs imported from other countries without fear of breaking the law, now that a five-year push in Congress for new rules has gained support in President Barack Obama’s budget.” On Wednesday, Sen. John McCain (R-AZ) and other lawmakers introduced “a proposal to allow drug imports. … Obama called for the changes in his budget last week, and views the measure as one way to reduce healthcare costs so that medical coverage for the uninsured can be expanded.” Data show that “brand-name drugs in other countries cost as much as 70 percent less than in the U.S.” Therefore, “allowing imports would save Americans $50 billion over the next decade, including $10 billion for the U.S. government, the lawmakers said.” Notably, the “Pharmaceutical Research and Manufacturers of America…opposes the legislation. The group has argued that allowing imports would open the door to unsafe, counterfeit medicines.” Meanwhile, “AARP, the largest advocacy group for older Americans, supported” the measure even when it was first introduced on former President George W. Bush.
        CongressDaily (3/5) notes that the lawmakers “expect this to pass,” particularly since “Obama announced in his budget a strong interest in implementing this policy.”

Read Full Post »

USA Today (1/19, Vergano) reported that, with the inauguration of President Barack Obama, “the politics of science” now “heads for uncharted waters.” Now, “scientists are hopeful that Obama, who has called for increased research spending, will bring a new dawn.” Obama once stated, “My administration will value science. We will make decisions based on the facts, and we understand that facts demand bold action.” Two areas in which change may happen are “in the White House’s attitude toward global warming,” and in “research involving human embryonic stem cells,” in which “Obama has pledged to reverse Bush’s funding limits.” The Obama administration will also appoint members of the “roughly 1,000 scientific advisory committees, called the ‘fifth arm of government’ by Harvard science policy expert Sheila Jasanoff.” These committee members “can exert tremendous influence on government decisions,” such as “the ones advising the Food and Drug Administration on whether new drugs are safe for approval to the market.”

Read Full Post »